FARRZYME™ High Avidity anti dsDNA Kit

FARRZYME is a selective EIA assay for the detection of high avidity IgG anti-dsDNA antibodies.

When used in combination with other assays, FARRZYME aids the diagnosis of Systemic Lupus Erythematosus (SLE) and lupus nephritis.

High avidity anti-dsDNA antibodies

Serological detection of anti-dsDNA antibodies can be an important indicator of disease activity in SLE. The association between high avidity serum IgG anti-dsDNA antibodies and renal inflammatory activity has been reported. Patients are at a higher risk of progressing to more severe disease if they have high avidity antibodies compared to those patients who have only lower avidity anti-dsDNA antibodies detectable.1, 2

The selectivity of FARRZYME for high avidity anti-dsDNA antibodies has been clearly demonstrated in the table below.

Monoclonal AntibodyHigh Avidity Antibody - 32B9 (9.6 x 10-7Kd)Low Avidity Antibody - 33H11 (6.6 x 10-7Kd)
FARRZYME (IU/mL)Strong PositiveNegative
Standard anti-dsDNA EIA (IU/mL)Strong PositiveStrong Positive

Calibration

The assay is calibrated in IU/mL against the WHO reference Wo80. A five point calibration curve is generated.

Result Interpretation

ResultInterpretation
< 30 IU/mLNegative
> 30 IU/mLPositive

Measuring Range

12.3 - 1000 IU/mL

Sensitivity

12.3 IU/mL

Return to list of Enzyme Immunoassays (EIA)

 

References

1. Isenberg D., Smeenk R. Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now? Lupus 2002;11:797-800
2. Isenberg, D.A., Manson, J.J., Ehrenstein, M.R., Rahman, A. Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatol 2007;0 kem112v:1-5